Close Menu

The Wall Street Journal Health Blog reports that many top people at Merck will keep their positions as the merger with Schering-Plough goes through. Merck's CEO, Dick Clark, will stay in charge. Also keeping their spots are Kenneth Frazier, the head of global human health, Peter Kim, the head of research labs, and Willie Deese, the head of manufacturing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.